Try our Advanced Search for more refined results

March 02, 2012

DEPOMED, INC. v. ACTAVIS ELIZABETH LLC et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 25, 2014

    Actavis Can't Sell Generic Gralise After Depomed IP Trial

    Actavis Elizabeth LLC is barred from producing and selling a generic version of timed-release Gralise after a New Jersey federal judge found that Actavis infringed several Depomed Inc. patents on the neuropathic pain medication, according to a ruling unsealed Monday following a seven-day bench trial in May.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login